What price range did Jian Xie’s FLGT share sale occur at?

The filing states the 1,193 shares were sold in multiple transactions at prices ranging from $19.83 to $20.00 per share. The reported $19.9053 figure is disclosed as the weighted-average sale price.

Fulgent Genetics executive sells 1,193 shares for taxes

Q: What insider transaction did FLGT executive Jian Xie report on this Form 4?

Jian Xie reported a sale of 1,193 FLGT common shares on 2026-08-27 at a weighted-average price of $19.9053 per share. The sale was made to satisfy tax withholding obligations from the vesting of restricted stock units granted on February 26, 2024.

Q: Was the FLGT insider sale by Jian Xie related to tax withholding?

Yes. The filing states the 1,193-share sale was conducted to satisfy tax withholding obligations arising from the vesting of restricted stock units that were granted to Jian Xie on February 26, 2024.

Q: How many FLGT shares does Jian Xie hold after this reported sale?

After the sale, Jian Xie directly held 362,051 FLGT common shares. An additional 220,816 shares are held indirectly through The Hsieh Family Dynasty Trust, where he serves on the investment committee and disclaims beneficial interest except for any pecuniary interest.

Q: Is Jian Xie’s indirect ownership of FLGT shares through a trust fully beneficial?

No. The filing explains that 220,816 FLGT shares are held by The Hsieh Family Dynasty Trust. Jian Xie serves on the trust’s investment committee and disclaims any beneficial interest in those shares except with respect to any pecuniary interest.

Fulgent Genetics, Inc. (FLGT) reported an insider transaction by President and COO Jian Xie.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Fulgent Genetics, Inc. (FLGT) reported an insider transaction by President and COO Jian Xie. On 2026-08-27, Xie sold 1,193 shares of common stock at a weighted-average price of $19.9053 per share to satisfy tax withholding obligations arising from the vesting of restricted stock units granted on February 26, 2024. After this sale, Xie directly held 362,051 shares and had an additional 220,816 shares held indirectly through The Hsieh Family Dynasty Trust, for which he serves on the investment committee and disclaims beneficial interest except for any pecuniary interest.

Insider Trade Summary

Net Seller: 1,193 shares

Net Sell 2 txns

Insider Xie Jian

Role President and COO

Sold 1,193 shs ($24K)

Type	Security	Shares	Price	Value
Sale	Common Stock ^{F1, F2}	1,193	$19.9053	$24K
holding	Common Stock ^F3	--	--	--

Holdings After Transaction: Common Stock — 362,051 shares (Direct); Common Stock — 220,816 shares (Indirect, By Trust)

Footnotes (3)

F1. The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.
F2. The shares were sold in multiple transactions at prices ranging from $19.83 to $20.00, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3. Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.

Key Figures

Shares sold: 1,193 shares of Common Stock Weighted-average sale price: $19.9053 per share Sale price range: $19.83 to $20.00 per share +3 more

6 metrics

Shares sold 1,193 shares of Common Stock Sale on 2026-08-27 to satisfy tax withholding obligations

Weighted-average sale price $19.9053 per share Weighted-average price for 1,193 shares sold on 2026-08-27

Sale price range $19.83 to $20.00 per share Multiple transactions comprising the 1,193-share sale

Direct holdings after transaction 362,051 shares of Common Stock Direct ownership by Jian Xie following the 2026-08-27 sale

Indirect holdings via Trust 220,816 shares of Common Stock Held by The Hsieh Family Dynasty Trust; Xie disclaims beneficial interest except pecuniary

RSU grant date February 26, 2024 Restricted stock units whose vesting triggered tax withholding

Key Terms

restricted stock units, weighted-average sale price, tax withholding obligations, pecuniary interest, +1 more

5 terms

restricted stock units financial

"tax withholding obligations that arose upon the vesting of certain restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted-average sale price financial

"The reported price reflects the weighted-average sale price."

tax withholding obligations financial

"sold by the reporting person to satisfy the tax withholding obligations"

pecuniary interest financial

"Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest"

indirect ownership financial

"Securities held by The Hsieh Family Dynasty Trust... indirect ownership"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did FLGT executive Jian Xie report on this Form 4?

Jian Xie reported a sale of 1,193 FLGT common shares on 2026-08-27 at a weighted-average price of $19.9053 per share. The sale was made to satisfy tax withholding obligations from the vesting of restricted stock units granted on February 26, 2024.

How many FLGT shares does Jian Xie hold after this reported sale?

After the sale, Jian Xie directly held 362,051 FLGT common shares. An additional 220,816 shares are held indirectly through The Hsieh Family Dynasty Trust, where he serves on the investment committee and disclaims beneficial interest except for any pecuniary interest.

Is Jian Xie’s indirect ownership of FLGT shares through a trust fully beneficial?

No. The filing explains that 220,816 FLGT shares are held by The Hsieh Family Dynasty Trust. Jian Xie serves on the trust’s investment committee and disclaims any beneficial interest in those shares except with respect to any pecuniary interest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/28/2026 - 06:06 PM EDT Accepted by SEC EDGAR 08/28/2026 - 06:06 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Xie Jian

(Last)

(First)

(Middle)

C/O FULGENT GENETICS, INC.

4399 SANTA ANITA AVENUE

(Street)

EL MONTE

CALIFORNIA

91731

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Fulgent Genetics, Inc. [ FLGT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/27/2026		S		1,193⁽¹⁾	D	$19.9053⁽²⁾	362,051	D
Common Stock								220,816	I	By Trust⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.

2. The shares were sold in multiple transactions at prices ranging from $19.83 to $20.00, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

3. Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.

	/s/ Paul Kim as Attorney-in-Fact	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR